Discordancy partitioning for validating potentially inconsistent pharmacogenomic studies

J. Sunil Rao, Hongmei Liu

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE) are two major studies that can be used to mine for therapeutic biomarkers for cancers of a large variety. Model validation using the two datasets however has proved challenging. Both predictions and signatures do not consistently validate well for models built on one dataset and tested on the other. While the genomic profiling seems consistent, the drug response data is not. Some efforts at harmonizing experimental designs has helped but not entirely removed model validation difficulties. In this paper, we present a partitioning strategy based on a data sharing concept which directly acknowledges a potential lack of concordance between datasets and in doing so, also allows for extraction of reproducible novel gene-drug interaction signatures as well as accurate test set predictions. We demonstrate these properties in a re-analysis of the GDSC and CCLE datasets.

Original languageEnglish (US)
Article number15169
JournalScientific reports
Issue number1
StatePublished - Dec 1 2017

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Discordancy partitioning for validating potentially inconsistent pharmacogenomic studies'. Together they form a unique fingerprint.

Cite this